Shestakova M V, Koshel' L V, Vagodin V A, Dedov I I
Ter Arkh. 2006;78(5):60-4.
To ascertain prognostic factors defining the risk of progression of diabetic nephropathy (DN) in patients with diabetes mellitus (DM) type 1 and 2 suffering from DM over 20 years.
A one-stage comparative trial studied 141 patients with DM type 1 and 149 patients with DM type 2 with DN of different severity and 20 year history of the disease. The follow-up study covered 34 CD-1 patients and 45 CD-2 patients with normo-, micro- and macroalbuminuria. The groups were made by the principle case-control. The control group consisted of 24 patients with DM-1 and 19 patients with DM-2 having stable renal function, the case group consisted of 10 and 26 patients, respectively, with DN progression. A total duration of the follow-up was 6 years. The end point of the analysis was chronic renal failure (CRF).
Multivariate regression analysis has shown that the following risk factors of microalbuminuria in DM-1 and DM-2 are independent: the level of HbA1c (RR 3,1 and 2.7, respectively) and duration of arterial hypertension (RR 2.1 and 2.0, respectively); proteinuria - HbA1c (RR 4.4 and 3.4, respectively), systolic blood pressure (RR 3.4 and 3.1, respectively), CRF - systolic blood pressure (RR 5.0 and 4.5, respectively), triglycerides (RR 2.8 and 4.9, respectively) and hemoglobin (RR 3.3 and 5.3, respectively). IN DM-2 other risk factors of CRF were male sex (RR 2.0), family history of hypertension (RR 3.8) and 24-h proteinuria > 2 g (RR 6.7).
Inadequate compensation of carbohydrate metabolism (HbA1c), arterial hypertension and dyslipidemia are main risk factors of MAU and its progression to proteinuria in DM patients. In progression of DN to CRF main risk factors are hypertension, dyslipidemia and severity of anemia.
确定1型和2型糖尿病病程超过20年患者糖尿病肾病(DN)进展风险的预后因素。
一项单阶段对照试验研究了141例1型糖尿病患者和149例2型糖尿病患者,他们患有不同严重程度的DN且病程达20年。随访研究涵盖了34例CD - 1患者和45例CD - 2患者,这些患者有正常蛋白尿、微量蛋白尿和大量蛋白尿。分组采用病例对照原则。对照组由24例肾功能稳定的1型糖尿病患者和19例2型糖尿病患者组成,病例组分别由10例和26例DN进展患者组成。随访总时长为6年。分析的终点是慢性肾衰竭(CRF)。
多因素回归分析表明,1型糖尿病和2型糖尿病中微量白蛋白尿的以下风险因素是独立的:糖化血红蛋白水平(RR分别为3.1和2.7)以及动脉高血压病程(RR分别为2.1和2.0);蛋白尿方面为糖化血红蛋白(RR分别为4.4和3.4)、收缩压(RR分别为3.4和3.1);慢性肾衰竭方面为收缩压(RR分别为5.0和4.5)、甘油三酯(RR分别为2.8和4.9)以及血红蛋白(RR分别为3.3和5.3)。在2型糖尿病中,慢性肾衰竭的其他风险因素为男性(RR为2.0)、高血压家族史(RR为3.8)以及24小时蛋白尿>2g(RR为6.7)。
碳水化合物代谢补偿不足(糖化血红蛋白)、动脉高血压和血脂异常是糖尿病患者微量白蛋白尿及其进展为蛋白尿的主要风险因素。在糖尿病肾病进展为慢性肾衰竭过程中,主要风险因素是高血压、血脂异常和贫血严重程度。